Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Adamas Pharma (ADMS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 219,866
  • Shares Outstanding, K 27,449
  • Annual Sales, $ 34,050 K
  • Annual Income, $ -131,000 K
  • 60-Month Beta 1.49
  • Price/Sales 6.44
  • Price/Cash Flow N/A
  • Price/Book 2.43

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate -1.13
  • Number of Estimates 5
  • High Estimate -1.07
  • Low Estimate -1.31
  • Prior Year -1.35
  • Growth Rate Est. (year over year) +16.30%

Price Performance

See More
Period Period Low Period High Performance
1-Month
7.43 +8.21%
on 03/14/19
12.57 -36.04%
on 03/04/19
-2.95 (-26.84%)
since 02/21/19
3-Month
7.43 +8.21%
on 03/14/19
12.57 -36.04%
on 03/04/19
+0.20 (+2.55%)
since 12/21/18
52-Week
7.42 +8.36%
on 12/20/18
32.90 -75.56%
on 05/18/18
-17.76 (-68.84%)
since 03/21/18

Most Recent Stories

More News
Best Relative Performance in the Biotechnology Industry Detected in Shares of Cytokinetics Inc (CYTK , ADMS , MYGN , FPRX , ALDR )

Here are the top 5 stocks in the Biotechnology industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

CYTK : 9.74 (-4.42%)
ADMS : 8.03 (+0.25%)
MYGN : 33.26 (+0.67%)
Adamas Announces New Employment Inducement Grant

Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) today announced that the compensation committee of the company's board of directors granted four new employees the option to purchase an aggregate of 56,600...

ADMS : 8.03 (+0.25%)
Watch for Adamas Pharmaceu to Potentially Rebound After Falling 31.28% Yesterday

Adamas Pharmaceu (NASDAQ:ADMS) traded in a range yesterday that spanned from a low of $8.19 to a high of $8.96. Yesterday, the shares fell 31.3%, which took the trading range below the 3-day low of $10.87...

ADMS : 8.03 (+0.25%)
Will R&D Focus Fuel DENTSPLY SIRONA's (XRAY) Earnings in Q4?

DENTSPLY SIRONA's (XRAY) overall growth strategy depends on product innovation and R&D focus, which is likely to drive the top line in Q4.

TGTX : 7.45 (+0.13%)
COO : 297.22 (+2.06%)
ADMS : 8.03 (+0.25%)
XRAY : 49.96 (+1.90%)
Adamas to Present at Two Upcoming Investor Conferences

Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a fully-integrated pharmaceutical company pioneering time-dependent medicines for central nervous system disorders, today announced that Gregory T. Went, Ph.D.,...

ADMS : 8.03 (+0.25%)
Adamas to Announce Fourth Quarter and Year-End 2018 Financial Results and Host Conference Call on March 4, 2019

Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) today announced that the company will report fourth quarter and year-end 2018 financial results on Monday, March 4, 2019, after market close. Subsequently, Adamas'...

ADMS : 8.03 (+0.25%)
Tenet Healthcare (THC) Q4 Earnings: What's in the Offing?

Tenet Healthcare's (THC) Q4 earnings are likely to suffer lower admissions due to divestitures.

FOLD : 13.68 (+2.32%)
ADMS : 8.03 (+0.25%)
FGEN : 56.01 (+1.69%)
THC : 30.47 (+2.87%)
Can Segmental Growth Fuel Veeva Systems' (VEEV) Q4 Earnings?

Focus on cloud-based services is likely to boost Veeva Systems' (VEEV) fiscal Q4 results.

ADC : 67.75 (+2.23%)
ADMS : 8.03 (+0.25%)
VEEV : 128.03 (+2.78%)
MASI : 137.01 (+2.55%)
AptarGroup (ATR) to Report Q4 Earnings: What's in Store?

AptarGroup (ATR) fourth-quarter results will benefit from successful product roll outs and focus on improving operations despite input cost inflation and customer plant shutdowns.

AMC : 15.44 (+3.21%)
ADMS : 8.03 (+0.25%)
ALSN : 46.26 (+0.22%)
ATR : 104.75 (+0.77%)
Milacron (MCRN) to Report Q4 Earnings: What's in Store?

Milacron's (MCRN) cost-reduction initiatives are expected to yield around $35 million of annual run-rate cost savings in the fourth quarter.

MCRN : 12.67 (-0.31%)
AMC : 15.44 (+3.21%)
ADMS : 8.03 (+0.25%)
ALSN : 46.26 (+0.22%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Sell with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade ADMS with:

Business Summary

Adamas Pharmaceuticals, Inc. is a specialty pharmaceutical company driven to improve the lives of those affected by chronic disorders of the central nervous system. The company seeks to achieve this by modifying the pharmacokinetic profiles of approved drugs to create novel therapeutics for use alone...

See More

Key Turning Points

2nd Resistance Point 8.40
1st Resistance Point 8.21
Last Price 8.03
1st Support Level 7.86
2nd Support Level 7.70

See More

52-Week High 32.90
Fibonacci 61.8% 23.17
Fibonacci 50% 20.16
Fibonacci 38.2% 17.15
Last Price 8.03
52-Week Low 7.42

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar